Background: Stem cell therapy has been proposed as a potential treatment strategy for ischemic cardiomyopathy in recent years. A variety of stem cells or stem cell-derived cells can potentially be used for transplantation. Despite improved cardiac function after treatment, one of the major problems is the poor integration between host and donor cells which can lead to post-transplantation arrhythmia and poor long-term outcome. Methods: In the present study, we cocultured murine embryonic stem cells (mES) with murine embryonic ventricular myocytes (mEVs) in hanging drops to assess the cellular interaction and function of mES-derived cardiomyocytes under these conditions. Results: We found that when mEVs are added to a culture system of embry...
Background: The optimal cell-matrix combination for robust and sustained myocardial restoration has ...
Cell transplantation may restore heart function in disease associated with loss or dysfunction of ca...
Induced pluripotent stem cell-derived cardiomyocytes (iPS-CMs) represent an attractive resource for ...
Stem cell transplantation holds great promise for the treatment of myocardial infarction injury. We ...
Background—Cardiomyocytes derived from human embryonic stem (hES) cells could be useful in restoring...
AIMS: Controversy exists in regard to the beneficial effects of transplanting cardiac or somatic pro...
Aims: Controversy exists in regard to the beneficial effects of transplanting cardiac or somatic pro...
AbstractRegeneration of the myocardium by transplantation of cardiomyocytes is an emerging therapeut...
Background-Pluripotent stem cells represent one promising source for cellular cardiomyoplasty. In th...
Background - We investigated whether differentiation of embryonic stem cells (ESCs) in ischemic myoc...
Heart failure is a leading cause of death in United States. One of the causes of heart failure is as...
Background—Pluripotent stem cells represent one promising source for cellular cardiomyoplasty. In th...
We have previously shown that mouse embryonic stem (ES) cells transplanted following myocardial infa...
Induced pluripotent stem (iPS) cells can efficiently differentiate into the three germ layers simila...
International audienceThe functional and architectural benefits of embryonic stem cells (ESC) and my...
Background: The optimal cell-matrix combination for robust and sustained myocardial restoration has ...
Cell transplantation may restore heart function in disease associated with loss or dysfunction of ca...
Induced pluripotent stem cell-derived cardiomyocytes (iPS-CMs) represent an attractive resource for ...
Stem cell transplantation holds great promise for the treatment of myocardial infarction injury. We ...
Background—Cardiomyocytes derived from human embryonic stem (hES) cells could be useful in restoring...
AIMS: Controversy exists in regard to the beneficial effects of transplanting cardiac or somatic pro...
Aims: Controversy exists in regard to the beneficial effects of transplanting cardiac or somatic pro...
AbstractRegeneration of the myocardium by transplantation of cardiomyocytes is an emerging therapeut...
Background-Pluripotent stem cells represent one promising source for cellular cardiomyoplasty. In th...
Background - We investigated whether differentiation of embryonic stem cells (ESCs) in ischemic myoc...
Heart failure is a leading cause of death in United States. One of the causes of heart failure is as...
Background—Pluripotent stem cells represent one promising source for cellular cardiomyoplasty. In th...
We have previously shown that mouse embryonic stem (ES) cells transplanted following myocardial infa...
Induced pluripotent stem (iPS) cells can efficiently differentiate into the three germ layers simila...
International audienceThe functional and architectural benefits of embryonic stem cells (ESC) and my...
Background: The optimal cell-matrix combination for robust and sustained myocardial restoration has ...
Cell transplantation may restore heart function in disease associated with loss or dysfunction of ca...
Induced pluripotent stem cell-derived cardiomyocytes (iPS-CMs) represent an attractive resource for ...